Weekly Reader - July 4, 2022

Weekly Reader - July 4, 2022
Photo by Towfiqu barbhuiya / Unsplash

Welcome to Finestra’s Weekly Reader, wherein we recount intriguing, important, or infamous health care-related stories you may have missed over the past week.

  • “Monkeypox cases surge as WHO stops short of declaring a global emergency” (Washington Post) - The World Health Organization is in a tough spot: Monkeypox cases are on the increase, but the organization does not want to sound the alarm – especially given the response to the COVID-19 global pandemic.
  • “Genetic Screening Results Just Got Harder to Handle Under New Abortion Rules” (Kaiser Health News) - Following the overturn of Roe v. Wade, states with abortion bans are discovering the unintended consequences of these policies. One of these is complicating genetic screenings.
  • “Abortion Pills Take the Spotlight as States Impose Abortion Bans” (NY Times) - Reproductive rights advocates have found that shipping abortion pills into states with abortion bans is easier than having patients travel out of state to obtain them.
  • “His-and-Hers Cataract Surgeries, But His Bill Was 20 Times as Much” (Kaiser Health News) - Why did two people with virtually the same surgery have such a drastic difference in the price when the bill finally arrived?
  • “Facebook Is Banning People Who Say They Will Mail Abortion Pills” (Vice) - Although abortion pills are FDA-approved, Meta initially took moves to ban advertisements for them on its Facebook and Instagram platforms.
  • “Three-Year Abortion Trends Vary Dramatically by State” (Kaiser Health News) - Although abortion is a nationwide issue in the United States, a deep dive into the statistics paints a complicated picture.